Mia Love, aged 49, passed away from glioblastoma, an aggressive brain cancer that remains difficult to treat, illustrating the limited advancements in effective treatments since 2005. Glioblastoma is notably challenging due to the blood-brain barrier, which prevents many drugs from reaching the tumor, and its creation of an immune-suppressive environment that hinders the effectiveness of immunotherapy. Researchers have made significant strides in understanding glioblastoma through funded research, pointing toward future therapeutic developments, even as current survival rates remain grim.
Glioblastoma is the most common type of malignant brain tumor, presenting significant treatment challenges due to its evasive nature and the complexities of the brain’s defenses.
Despite the slow progress in treatment, advancements in understanding glioblastoma are being made, indicating potential for promising new therapeutic approaches.
Collection
[
|
...
]